EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials

Alessandra Boccaccino, Daniele Rossini, Alessandra Raimondi, Martina Carullo, Sara Lonardi, Federica Morano, Daniele Santini, Gianluca Tomasello, Monica Niger, Alberto Zaniboni, Francesca Daniel, Sara Bustreo und 7 weitere

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.05.001 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Alessandra Boccaccino und 18 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Oncology, University Hospital of Pisa, Pisa, Italy and Department of Translational Research and New Technologies in Medicine and Surgery, Uni…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsColonic NeoplasmsRectal NeoplasmsHumansBevacizumabPanitumumabCamptothecinFluorouracilAntineoplastic Combined Chemotherapy ProtocolsLeucovorin

Stichwörter der Autor:innen

Adverse eventsFOLFOXIRIMetastatic colorectal cancerToxicity over Time (ToxT)

Substanzen

BevacizumabPanitumumabCamptothecinFluorouracilLeucovorin

Autor:innen und Institutionen

  • Unit of Oncology, University Hospital of Pisa, Pisa, Italy and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 67, 56126, Pisa, Italy.
  • Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Medical Oncology 3, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Oncologia Medica Università Campus Biomedico, Rome, Italy and UOC Oncologia Universitaria, Sapienza University of Rome, Polo Pontino, Italy.
  • Oncologia Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Milano, Italy.
  • Medical Oncology, Fondazione Poliambulanza, Brescia, Italy.

Zitieren

APA

Boccaccino, A., Rossini, D., Raimondi, A., Carullo, M., Lonardi, S., Morano, F., Santini, D., Tomasello, G., Niger, M., Zaniboni, A., Daniel, F., Bustreo, S., Procaccio, L., Clavarezza, M., Cupini, S., Libertini, M., Palermo, F., Pietrantonio, F., & Cremolini, C. (2023). Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.05.001

Vancouver

Boccaccino A, Rossini D, Raimondi A, Carullo M, Lonardi S, Morano F, et al. Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.05.001

BibTeX
@article{Boccaccino2023,
  author = {Boccaccino, Alessandra and Rossini, Daniele and Raimondi, Alessandra and Carullo, Martina and Lonardi, Sara and Morano, Federica and Santini, Daniele and Tomasello, Gianluca and Niger, Monica and Zaniboni, Alberto and Daniel, Francesca and Bustreo, Sara and Procaccio, Letizia and Clavarezza, Matteo and Cupini, Samanta and Libertini, Michela and Palermo, Federica and Pietrantonio, Filippo and Cremolini, Chiara},
  title = {Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.05.001}
}
Kostenlos starten →